Chordae Tendineae: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by drspine

Chordae Tendineae Introduction (What it is)

Chordae Tendineae are thin, tough, cord-like structures inside the heart.
They connect the mitral and tricuspid valve leaflets to the papillary muscles in the ventricles.
Their plain role is to help the valve close without “flipping backward” during contraction.
They are commonly discussed in echocardiography reports and in mitral or tricuspid valve repair surgery.

Why Chordae Tendineae used (Purpose / benefits)

Chordae Tendineae are not a medication or device that clinicians “use” in the usual sense—they are normal anatomy that makes atrioventricular (AV) valves work properly. Their importance comes up because many common valve problems involve the chordae directly, and modern structural heart care often aims to preserve or reconstruct them.

In general terms, the chordae address the problem of valve instability during ventricular contraction. When the left ventricle (LV) or right ventricle (RV) squeezes, pressure rises sharply. The mitral valve (left side) and tricuspid valve (right side) must close quickly and stay closed. Chordae Tendineae act like tensioned cords that restrain the valve leaflets, helping prevent valve prolapse (leaflets billowing backward into the atrium) and reducing valve regurgitation (backward leakage of blood).

Key benefits of normal, intact chordae (and of preserving or reconstructing them when treating valve disease) include:

Stable valve closure under high pressure, especially in the LV.
Reduced regurgitation risk when leaflet support is maintained.
Coordinated ventricular–valvular function, because papillary muscles and chordae link valve mechanics to ventricular contraction.
A surgical target for repair, because elongated or ruptured chordae can sometimes be replaced with artificial “neochordae” rather than replacing the entire valve (varies by clinician and case).

Clinical context (When cardiologists or cardiovascular clinicians use it)

Chordae Tendineae are referenced, assessed, or managed in practice in scenarios such as:

Evaluation of a heart murmur where mitral regurgitation or tricuspid regurgitation is suspected.
Echocardiography findings describing chordal elongation, rupture, flail leaflet, or prolapse.
Degenerative mitral valve disease (for example, myxomatous change) where chordal structure is central to the mechanism of regurgitation.
Infective endocarditis affecting valve leaflets and occasionally involving chordae, contributing to acute severe regurgitation.
Ischemic (functional) mitral regurgitation, where ventricular remodeling can displace papillary muscles and change chordal tension.
Cardiac surgery planning, especially for mitral or tricuspid valve repair strategies that preserve native chordae or replace damaged ones.
Postoperative follow-up, where imaging assesses valve function after chordal repair or chordal-sparing valve replacement.

Contraindications / when it’s NOT ideal

Because Chordae Tendineae are anatomy rather than a therapy, “contraindications” apply mainly to specific repair techniques involving chordae (such as chordal replacement or chordal-sparing approaches). Situations where a chordae-focused strategy may be less suitable, or where another approach may be preferred, include:

Extensive leaflet destruction (for example, severe infection-related damage) where there is insufficient healthy tissue to support a durable repair (varies by clinician and case).
Severe calcification of the valve apparatus (leaflets, annulus, or subvalvular structures) that limits repair options or leaflet mobility.
Complex multi-segment pathology where repair is technically challenging and replacement may be considered (varies by clinician and case).
Marked ventricular dysfunction or remodeling where the primary problem is ventricular geometry and tethering rather than isolated chordal failure; chordal work alone may not address the mechanism.
Right-sided valve disease driven by pulmonary hypertension or severe annular dilation, where annular intervention may be more central than chordal intervention (varies by clinician and case).
Material- or technique-related limitations for artificial chordae (for example, choice of suture material, surgeon experience, and patient anatomy), where alternative repair methods may be used (varies by material and manufacturer).

How it works (Mechanism / physiology)

At a high level, Chordae Tendineae are part of the subvalvular apparatus—the system beneath the mitral and tricuspid valves that includes the valve leaflets, chordae, papillary muscles, and adjacent ventricular wall.

Mechanism and physiologic principle

During ventricular systole (when the ventricle contracts), pressure rises and pushes the valve leaflets toward the atrium.
The papillary muscles contract at the same time as the ventricular wall, pulling on the chordae.
Chordae Tendineae convert that pull into tension on the leaflets, helping the leaflet edges meet (coapt) and preventing excessive backward motion.

This is not the same as “pulling the valve shut.” The valve closes primarily because of pressure differences and leaflet geometry. The chordae provide restraint and alignment, reducing the chance of prolapse or flail.

Relevant cardiovascular anatomy

Mitral valve (left heart): Between the left atrium and left ventricle; typically has anterior and posterior leaflets supported by chordae attaching to two papillary muscle groups.
Tricuspid valve (right heart): Between the right atrium and right ventricle; typically has three leaflets with chordal attachments to papillary muscles.
Papillary muscles: Muscular projections in the ventricles that serve as anchoring points for chordae.
Chordae structure: Often described as primary (marginal), secondary (basal/strut), and sometimes tertiary chordae, reflecting where they attach and how they support leaflet motion.

Time course and clinical interpretation

Chordae Tendineae function is continuous—every heartbeat depends on coordinated leaflet, chordal, and papillary muscle mechanics. When chordae become elongated (too long) or rupture (tear), regurgitation can develop suddenly or gradually depending on the cause:

Acute chordal rupture can lead to abrupt worsening of regurgitation, sometimes with shortness of breath and pulmonary congestion.
Chronic elongation can lead to progressive prolapse and gradually worsening regurgitation.

“Reversibility” mainly applies to the underlying cause (for example, remodeling after myocardial infarction) rather than the chordae themselves. Damaged chordae generally do not “heal back” to normal function in a predictable way; management decisions vary by clinician and case.

Chordae Tendineae Procedure overview (How it’s applied)

Chordae Tendineae are evaluated and discussed across imaging and surgical planning. They are not a stand-alone test, but they are a key structure assessed during valve workups and interventions.

A typical high-level workflow looks like this:

Evaluation / exam – History and physical exam may suggest valve disease (for example, a murmur). – Imaging—most often transthoracic echocardiography (TTE)—assesses valve anatomy, leaflet motion, regurgitation severity, ventricular size/function, and visible chordal abnormalities.
Preparation (when intervention is being considered) – Further imaging may be performed, such as transesophageal echocardiography (TEE) for more detailed valve and chordal assessment. – The care team evaluates whether the mechanism is prolapse/flail (often chordal-related) versus tethering/functional regurgitation (often ventricular-geometry-related).
Intervention / treatment approach (if needed) – In valve repair, clinicians may preserve native chordae, shorten/transfer chordae in selected cases, or create artificial chordae (“neochordae”) using surgical suture material (varies by clinician and case; varies by material and manufacturer). – In valve replacement, many techniques aim to preserve portions of the subvalvular apparatus (particularly on the mitral side) to maintain ventricular function, when feasible (varies by clinician and case).
Immediate checks – Intraoperative or post-procedural echocardiography assesses leaflet coaptation, residual regurgitation/stenosis, and overall ventricular performance.
Follow-up – Follow-up visits and periodic echocardiography track valve function and heart chamber remodeling over time, especially after repair involving chordal reconstruction.

Types / variations

Chordae Tendineae vary by location, attachment, and clinical context. Common ways clinicians describe variation include:

Left-sided vs right-sided
Mitral chordae (left heart) are often emphasized because LV pressures are high and mitral regurgitation is common.
Tricuspid chordae can also be involved in regurgitation, congenital variation, or device-related interactions (varies by case).
Primary, secondary, and tertiary chordae (functional categories)
Primary (marginal) chordae attach near the leaflet edge and help prevent edge prolapse.
Secondary chordae attach more centrally and contribute to leaflet shape and load distribution.
Tertiary chordae (when described) may attach to the ventricular wall or basal regions, particularly discussed in mitral anatomy descriptions.
Normal variants
Chordae thickness and branching pattern vary between individuals.
Some hearts have structures sometimes termed false tendons (fibromuscular bands in the ventricle) that are distinct from true chordae and do not attach to valve leaflets.
Pathologic variations
Elongated chordae (often linked to degenerative valve disease).
Ruptured chordae causing a flail leaflet (a leaflet segment that loses restraint and flips backward).
Thickened or shortened chordae that can restrict leaflet motion.
Tethered chordae in functional regurgitation, where papillary muscle displacement changes tension vectors.
Native chordae vs artificial chordae (neochordae)
In repair, surgeons may implant artificial chordae to replace damaged ones; materials and techniques vary by clinician and case and by material/manufacturer.

Pros and cons

Pros:

Maintain stable leaflet positioning during ventricular contraction.
Help prevent prolapse and flail, key mechanisms of regurgitation.
Provide a repairable target in many degenerative mitral valve problems (varies by clinician and case).
Support ventricular–valvular coupling, linking papillary muscle motion to valve competence.
Allow mechanistic classification of regurgitation (for example, prolapse vs tethering) when interpreted on echocardiography.
In some surgeries, preservation/reconstruction may help maintain more physiologic ventricular mechanics (varies by clinician and case).

Cons:

Chordae can rupture or elongate, leading to sudden or progressive regurgitation.
They may be difficult to visualize fully on standard imaging in some patients; advanced imaging may be needed.
Repair involving chordae can be technically demanding, and results can vary with anatomy and operator experience (varies by clinician and case).
Artificial chordae outcomes can depend on material choice and technique, and long-term performance varies by material and manufacturer.
Chordal pathology may coexist with annular dilation, leaflet disease, or ventricular remodeling, so addressing chordae alone may not correct the full problem.
Some disease processes (calcification, infection, scarring) can make chordal-preserving approaches less feasible (varies by clinician and case).

Aftercare & longevity

Aftercare is not about caring for chordae directly, but about monitoring the valve condition and overall heart function when chordal disease is present or after a repair/replacement that involves the subvalvular apparatus.

Factors that can influence durability and long-term outcomes include:

Underlying cause of valve disease
Degenerative prolapse, ischemic remodeling, inflammatory or infectious causes can have different trajectories and recurrence risks (varies by clinician and case).
Severity at diagnosis
Chamber enlargement, pulmonary pressures, and ventricular function at the time of evaluation can influence long-term remodeling.
Type of intervention (if performed)
Repair strategies (including neochordae) versus replacement, and whether the subvalvular apparatus is preserved, can influence follow-up findings (varies by clinician and case).
Comorbidities and risk factors
Conditions such as coronary artery disease, hypertension, atrial fibrillation, lung disease, kidney disease, and diabetes can affect symptoms and recovery patterns.
Follow-up and surveillance
Periodic clinical review and echocardiography are commonly used to monitor regurgitation severity and ventricular size/function over time.
Rehabilitation and functional recovery
When surgery occurs, recovery and return of exercise tolerance may be influenced by baseline conditioning and participation in supervised rehabilitation programs, when offered (varies by clinician and case).

This information is general and not a substitute for individualized care planning.

Alternatives / comparisons

Because Chordae Tendineae are anatomy, “alternatives” usually means alternative ways of evaluating chordal function or treating valve dysfunction when chordae are involved.

Common comparisons include:

Observation/monitoring vs intervention
Mild or stable regurgitation may be followed with periodic assessment, while more severe regurgitation or symptoms may prompt consideration of procedural options (varies by clinician and case).
Medication vs structural treatment
Medications may help manage symptoms or contributing conditions (like blood pressure or fluid overload), but they do not directly “repair” ruptured or elongated chordae. Structural repair targets the mechanical cause when appropriate.
Echocardiography (TTE/TEE) vs other imaging
TTE is typically first-line for valve assessment.
TEE can offer higher-resolution views of leaflets and chordal involvement in many cases.
Cardiac MRI or CT may be used in selected scenarios to clarify anatomy, quantify regurgitation, or plan procedures (varies by clinician and case).
Valve repair vs valve replacement
Repair may include chordal reconstruction and aims to restore native valve function when feasible.
Replacement removes or excludes portions of the native valve; chordal-sparing techniques may preserve subvalvular continuity, particularly for the mitral valve (varies by clinician and case).
Surgical vs catheter-based approaches
Many chordal repairs are surgical, but catheter-based mitral interventions can address regurgitation through other mechanisms (for example, leaflet approximation or annular approaches). The best fit depends on valve anatomy, mechanism of regurgitation, and patient factors (varies by clinician and case).

Chordae Tendineae Common questions (FAQ)

Q: Where are Chordae Tendineae located?
They are inside the ventricles of the heart, connecting the mitral and tricuspid valve leaflets to papillary muscles. You can think of them as internal support cords that stabilize valve leaflets during each heartbeat.

Q: What happens if Chordae Tendineae rupture?
A rupture can cause part of a valve leaflet to lose support and move abnormally, sometimes described as a flail leaflet. This can lead to worsening valve regurgitation, which may be acute or may present more gradually depending on the cause and severity.

Q: How do clinicians detect chordal problems?
Echocardiography is the main tool. A transthoracic echocardiogram often identifies prolapse, flail segments, and regurgitation severity, while transesophageal echocardiography may provide more detailed views when needed.

Q: Is a chordal problem painful?
The chordae themselves do not have a typical “pain signal” patients can feel. Symptoms, when present, are more often related to valve regurgitation and its effects—such as shortness of breath, reduced exercise tolerance, or palpitations—rather than pain.

Q: Can Chordae Tendineae be repaired or replaced?
In selected cases, surgeons can repair the valve and reconstruct support using techniques that preserve native chordae or implant artificial neochordae. Whether this is appropriate depends on the valve involved, the mechanism of regurgitation, tissue quality, and overall clinical context (varies by clinician and case).

Q: How long do results last after chordal reconstruction?
Durability varies based on the underlying disease, the specific repair strategy, and patient-specific anatomy. Long-term follow-up typically relies on symptoms and periodic imaging rather than a fixed expected duration.

Q: Is chordal surgery considered safe?
Any heart valve procedure carries risk, and risk depends on age, heart function, comorbidities, and procedural complexity. Safety profiles differ across repair vs replacement and across surgical vs catheter-based approaches (varies by clinician and case).

Q: Will I need to stay in the hospital if chordae are involved in a procedure?
If chordal work is part of open cardiac surgery, hospitalization is typical. Some catheter-based valve procedures may have shorter stays, but whether they apply to a chordal mechanism depends on anatomy and procedure selection (varies by clinician and case).

Q: Are there activity restrictions with chordal disease?
Recommendations depend on the severity of regurgitation, symptoms, heart rhythm, and ventricular function. Clinicians often individualize guidance based on imaging and functional status rather than chordae findings alone (varies by clinician and case).

Q: What does it mean when a report says “chordal thickening” or “chordal rupture”?
These terms describe structural changes seen or suspected on imaging. Thickening may be associated with degenerative or inflammatory processes, while rupture indicates loss of continuity that can destabilize leaflet motion and contribute to regurgitation.